Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
6.27
+2.08 (49.64%)
At close: Oct 23, 2026, 4:00 PM EDT
6.86
+0.59 (9.41%)
After-hours: Oct 23, 2026, 7:59 PM EDT
Bolt Biotherapeutics Employees
Bolt Biotherapeutics had 23 employees as of December 31, 2025. The number of employees decreased by 29 or 55.77% compared to the previous year. That makes Bolt Biotherapeutics the 38,049th largest employer in the world and 5,414th in the United States.
Employees
23
Change (1Y)
-29
Growth (1Y)
-55.77%
Revenue / Employee
$204,348
Profits / Employee
-$1,249,522
Market Cap
12.08M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 23 | -29 | -55.77% |
| Sep 30, 2025 | 40 | -12 | -23.08% |
| Dec 31, 2024 | 52 | -48 | -48.00% |
| Dec 31, 2023 | 100 | 6 | 6.38% |
| Dec 31, 2022 | 94 | 3 | 3.30% |
| Dec 31, 2021 | 91 | 26 | 40.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Pluri | 113 |
| Cerenome | 28 |
| Daré Bioscience | 24 |
| SeaStar Medical Holding | 18 |
| Lipocine | 14 |
| Tvardi Therapeutics | 12 |
| Actuate Therapeutics | 12 |
BOLT News
- Just now - Bolt Biotherapeutics Press release: M&A announcement - Filings
- 1 day ago - Why Is Penny Stock Bolt Biotherapeutics (BOLT) Up 62% Today? - TipRanks
- 1 day ago - Bolt Biotherapeutics Inc trading resumes - TheFly
- 1 day ago - Bolt Biotherapeutics acquires Prana Therapies - TheFly
- 1 day ago - Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications - GlobeNewsWire
- 1 day ago - Bolt Biotherapeutics Inc trading halted, news pending - TheFly
- 2 months ago - Bolt Biotherapeutics reports Q2 EPS ($4.57) vs. ($4.46) last year - TheFly
- 2 months ago - Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire